Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$662M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$116M |
| 3 |
Broadcom
AVGO
|
+$96.2M |
| 4 |
Walmart Inc
WMT
|
+$91.2M |
| 5 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$77.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Bitcoin Trust
IBIT
|
+$175M |
| 2 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$152M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$149M |
| 4 |
INFN
Infinera Corporation Common Stock
INFN
|
+$108M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$70.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.92% |
| 2 | Financials | 4.33% |
| 3 | Healthcare | 3.85% |
| 4 | Consumer Discretionary | 3.59% |
| 5 | Industrials | 3.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Thermo Fisher Scientific
TMO
$233B
| $12.6M | 0.04% |
25,230
+16,739
| +197% | +$9.07M |
|
377
CALL
Alibaba
BABA
$286B
| $12.5M | 0.04% |
94,800
+59,500
| +169% | +$6.86M |
|
|
GRMN
378
Garmin
GRMN
$56.9B
| $12.5M | 0.04% |
+57,640
| New | +$12.5M |
|
379
Nike
NKE
$60.5B
| $12.5M | 0.04% |
197,125
-124,748
| -39% | -$9.18M |
|
380
PUT
Vistra
VST
$45.7B
| $12.4M | 0.04% |
105,900
+39,400
| +59% | +$5.89M |
|
381
Wells Fargo
WFC
$254B
| $12.4M | 0.04% |
173,000
-94,236
| -35% | -$7.08M |
|
382
Progyny
PGNY
$1.97B
| $12.4M | 0.04% |
552,938
+392,519
| +245% | +$8.45M |
|
383
PUT
Astera Labs
ALAB
$49.4B
| $12.3M | 0.04% |
205,800
+197,300
| +2,321% | +$18.3M |
|
384
American Eagle Outfitters
AEO
$2.71B
| $12.2M | 0.04% |
1,051,636
+885,255
| +532% | +$12.7M |
|
385
Lyft
LYFT
$6.61B
| $12.2M | 0.04% |
+1,029,195
| New | +$13.4M |
|
386
Archer Aviation
ACHR
$4.85B
| $12.1M | 0.04% |
1,703,379
+771,156
| +83% | +$6.84M |
|
387
CALL
Interactive Brokers
IBKR
$42.5B
| $12.1M | 0.04% |
292,400
+113,200
| +63% | +$5.61M |
|
388
Micron Technology
MU
$1.09T
| $12.1M | 0.04% |
138,854
-158,544
| -53% | -$15.2M |
|
389
Cal-Maine
CALM
$3.87B
| $12M | 0.04% |
+132,559
| New | +$13.1M |
|
390
PUT
First Solar
FSLR
$23B
| $12M | 0.04% |
95,000
+46,200
| +95% | +$7.21M |
|
391
State Street SPDR S&P Biotech ETF
XBI
$11.2B
| $11.9M | 0.04% |
147,091
+72,307
| +97% | +$6.46M |
|
392
CALL
Abercrombie & Fitch
ANF
$4.84B
| $11.9M | 0.04% |
156,200
+152,500
| +4,122% | +$16.4M |
|
393
ATI
ATI
$28.2B
| $11.9M | 0.04% |
+228,272
| New | +$13M |
|
394
PUT
Johnson & Johnson
JNJ
$651B
| $11.9M | 0.04% |
71,600
+26,900
| +60% | +$4.21M |
|
395
CALL
Oracle
ORCL
$422B
| $11.9M | 0.04% |
84,900
-9,800
| -10% | -$1.6M |
|
396
Bunge Global
BG
$21.7B
| $11.8M | 0.04% |
154,655
-215,831
| -58% | -$16.2M |
|
397
CALL
General Mills
GIS
$21.4B
| $11.8M | 0.04% |
197,500
+183,400
| +1,301% | +$11M |
|
398
FIVE9
FIVN
$2.45B
| $11.8M | 0.04% |
432,997
+246,994
| +133% | +$9.06M |
|
399
Sensata Technologies
ST
$6.23B
| $11.7M | 0.04% |
483,240
+274,094
| +131% | +$7.6M |
|
400
Hasbro
HAS
$13.2B
| $11.7M | 0.04% |
190,046
+174,222
| +1,101% | +$10.5M |
|
Similar funds
Paul Tudor Jones's Q1 2025 Portfolio in Review
As of Q1 2025, Paul Tudor Jones held 3,818 positions worth $30.1B, up 15% from $26.3B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Paul Tudor Jones deployed $6.13B of net new capital in Q1 2025, opening 874 new positions and adding to 1,161 existing holdings. Its largest new stake was Intra-Cellular Therapies Inc.: 621,815 shares worth $82M.
By sector, the portfolio is most concentrated in Technology at 5.9% of assets, down from 6.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was iShares Bitcoin Trust, an estimated $175M trimmed.
- Paul Tudor Jones's largest Q1 2025 buy was Intra-Cellular Therapies Inc.: 621,815 shares worth $82M.
- Paul Tudor Jones added most to iShares Russell 2000 ETF in Q1 2025, an estimated $662M increase.
- Paul Tudor Jones's biggest Q1 2025 reduction was iShares Bitcoin Trust, cutting an estimated $175M.
- Paul Tudor Jones fully exited Infinera Corporation Common Stock in Q1 2025, selling an estimated $108M.
- Paul Tudor Jones's ten largest holdings make up 40% of its $30.1B portfolio in Q1 2025.
- Paul Tudor Jones opened 874 new positions and closed 844 in Q1 2025.
- Paul Tudor Jones's portfolio value rose 15% quarter-over-quarter to $30.1B.
Based on Tudor Investment Corp's 13F filing for Q1 2025, filed 15 May 2025.